Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Angiographic classification of patterns of restenosis following femoropopliteal artery intervention: A proposed scoring system.

Garcia LA, Rocha-Singh KJ, Krishnan P, Zeller T, Tepe G, Fleming M, Granada JF, Turco MA, Tieché C, Jaff MR.

Catheter Cardiovasc Interv. 2017 Aug 10. doi: 10.1002/ccd.27198. [Epub ahead of print]

PMID:
28795488
2.

Stenting for ST-segment elevation myocardial infarction is associated with less neointimal hyperplasia in the pooled IVUS analysis from HORIZONS-AMI and the TAXUS IV and V and ATLAS workhorse, long lesion, and direct stent studies.

Kobayashi N, Maehara A, Allocco D, Witzenbichler B, Ellis SG, Turco MA, Ormiston JA, Guagliumi G, Jiang S, McAndrew TC, Dawkins KD, Stone GW, Mintz GS, Weissman NJ.

Coron Artery Dis. 2014 Nov;25(7):575-81. doi: 10.1097/MCA.0000000000000131.

PMID:
24911615
3.

Strategies for multivessel revascularization in patients with diabetes.

Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S 3rd, Bertrand M, Fuster V; FREEDOM Trial Investigators.

N Engl J Med. 2012 Dec 20;367(25):2375-84. doi: 10.1056/NEJMoa1211585. Epub 2012 Nov 4.

4.

Neurologic safety event rates in the SENTIS trial control population.

Lutsep HL, Altafullah IM, Roberts R, Silverman IE, Turco MA, Vaishnav AG.

Acta Neurol Scand. 2013 Feb;127(2):e5-7. doi: 10.1111/ane.12005. Epub 2012 Sep 18.

PMID:
22988905
5.

A provisional strategy for treating true bifurcation lesions employing a scoring balloon for the side branch: final results of the AGILITY trial.

Weisz G, Metzger DC, Liberman HA, O'Shaughnessy CD, Douglas JS Jr, Turco MA, Mehran R, Gershony G, Leon MB, Moses JW.

Catheter Cardiovasc Interv. 2013 Sep 1;82(3):352-9. doi: 10.1002/ccd.24630. Epub 2013 Mar 9.

PMID:
22927100
6.

Economic modeling of new stent platforms to evaluate cost effectiveness: analysis of the TAXUS Liberté versus TAXUS express stents.

Turco MA, Kansal AR, Stern S, Amorosi SL, Underwood PL, Lissovoy GD, Dawkins KD.

J Interv Cardiol. 2012 Aug;25(4):353-63. doi: 10.1111/j.1540-8183.2012.00737.x. Epub 2012 May 22.

PMID:
22612261
7.

Impact of drug-eluting stents on distal vessels.

Wakabayashi K, Mintz GS, Weissman NJ, Stone GW, Ellis SG, Grube E, Ormiston JA, Turco MA, Pakala R, Xue Z, Desale S, Laynez-Carnicero A, Romaguera R, Sardi G, Pichard AD, Waksman R.

Circ Cardiovasc Interv. 2012 Apr;5(2):211-9. doi: 10.1161/CIRCINTERVENTIONS.111.965780. Epub 2012 Apr 10.

8.

Propensity-matched patient-level comparison of the TAXUS Liberté and TAXUS element (ION) paclitaxel-eluting stents.

Kereiakes DJ, Cannon LA, Ormiston JA, Turco MA, Mann T, Mishkel GJ, McGarry T, Wang H, Underwood P, Dawkins KD.

Am J Cardiol. 2011 Sep 15;108(6):828-37. doi: 10.1016/j.amjcard.2011.05.011. Epub 2011 Jul 30.

PMID:
21803319
10.

The Integrity bare-metal stent made by continuous sinusoid technology.

Turco MA.

Expert Rev Med Devices. 2011 May;8(3):303-6. doi: 10.1586/erd.11.2.

PMID:
21542702
11.

Long-term benefit of the TAXUS Liberté stent in small vessels and long lesions. TAXUS ATLAS program.

Ormiston JA, Turco MA, Hall JJ, Cannon LA, Yakubov SJ, Lucca MJ, Stone GW, O'Shaughnessy CD, Kozina JA, Gilchrist IC, Bertolet BD, Worthley SG, Underwood PL, Dawkins KD.

Circ J. 2011;75(5):1120-9. Epub 2011 Apr 1.

12.

Influence of sex on long-term outcomes after percutaneous coronary intervention with the paclitaxel-eluting coronary stent: results of the "TAXUS Woman" analysis.

Mikhail GW, Gerber RT, Cox DA, Ellis SG, Lasala JM, Ormiston JA, Stone GW, Turco MA, Joshi AA, Baim DS, Colombo A.

JACC Cardiovasc Interv. 2010 Dec;3(12):1250-9. doi: 10.1016/j.jcin.2010.08.020.

13.

President's page: Quality and appropriateness of care: the response to allegations and actions needed by the cardiovascular professional.

Brindis R, Goldberg SD, Turco MA, Dean LS.

J Am Coll Cardiol. 2011 Jan 4;57(1):111-3. doi: 10.1016/j.jacc.2010.12.006. No abstract available.

14.

Quality and appropriateness of care: the response to allegations and actions needed by the cardiovascular professional.

Brindis RG, Goldberg SD, Turco MA, Dean LS.

Catheter Cardiovasc Interv. 2011 Jan 1;77(1):2-4. doi: 10.1002/ccd.22935. No abstract available.

PMID:
21181966
15.

Improved strut coverage and less late incomplete apposition with thin-strut TAXUS Liberté vs. TAXUS Express: the importance of stent platform design for drug-eluting stents.

Weissman NJ, Turco MA, Ormiston JA, Mann T, Cannon LA, McGarry TF, Webster MW, Hall JJ, Lucca MJ, Mishkel GJ, Wu CJ, Mandinov L, Dawkins KD.

Cardiovasc Revasc Med. 2011 Jul-Aug;12(4):247-57. doi: 10.1016/j.carrev.2010.09.008. Epub 2010 Dec 3.

PMID:
21130708
16.

Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies.

Steinberg DH, Mintz GS, Mandinov L, Yu A, Ellis SG, Grube E, Dawkins KD, Ormiston J, Turco MA, Stone GW, Weissman NJ.

JACC Cardiovasc Interv. 2010 May;3(5):486-94. doi: 10.1016/j.jcin.2010.03.007.

17.

The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesions.

Uchida T, Popma J, Stone GW, Ellis SG, Turco MA, Ormiston JA, Muramatsu T, Nakamura M, Nanto S, Yokoi H, Baim DS.

JACC Cardiovasc Interv. 2010 Apr;3(4):403-11. doi: 10.1016/j.jcin.2010.01.010.

18.

Contemporary incidence and predictors of major adverse cardiac events after saphenous vein graft intervention with embolic protection (an AMEthyst trial substudy).

Naidu SS, Turco MA, Mauri L, Coolong A, Popma JJ, Kereiakes DJ.

Am J Cardiol. 2010 Apr 15;105(8):1060-4. doi: 10.1016/j.amjcard.2009.12.004. Epub 2010 Feb 20.

PMID:
20381653
19.

Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.

Doi H, Maehara A, Mintz GS, Yu A, Wang H, Mandinov L, Popma JJ, Ellis SG, Grube E, Dawkins KD, Weissman NJ, Turco MA, Ormiston JA, Stone GW.

JACC Cardiovasc Interv. 2009 Dec;2(12):1269-75. doi: 10.1016/j.jcin.2009.10.005.

20.

Long-term paclitaxel-eluting stent outcomes in elderly patients.

Forman DE, Cox DA, Ellis SG, Lasala JM, Ormiston JA, Stone GW, Turco MA, Wei JY, Joshi AA, Dawkins KD, Baim DS.

Circ Cardiovasc Interv. 2009 Jun;2(3):178-87. doi: 10.1161/CIRCINTERVENTIONS.109.855221. Epub 2009 Jun 2.

Supplemental Content

Loading ...
Support Center